TITLE

The value of contrast enhanced ultrasound in the evaluation of the nature of portal vein thrombosis

AUTHOR(S)
Dănilă, Mirela; Sporea, Ioan; Popescu, Alina; Şirli, Roxana; Şendroiu, Mădălina; Dănilă, Mirela; Sirli, Roxana; Sendroiu, Mădălina
PUB. DATE
June 2011
SOURCE
Medical Ultrasonography;Jun2011, Vol. 13 Issue 2, p102
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Unlabelled: Portal vein thrombosis (PVT) is a relatively common complication in patients with liver cirrhosis and hepatocellular carcinoma, but might also occur in the absence of liver disease. Ultrasound (US) is the first imaging method used for assessing PVT. the Purpose: To evaluate the utility of contrast-enhanced ultrasound (CEUS) for the differentiation between benign and malignant PVT. Materials and Methods: from October 2009 to October 2010, 38 PVTs were evaluated by means of ultrasound (standard, Doppler and CEUS). 29 PVT were in patients with liver cirrhosis and 9 in subjects without liver cirrhosis. Results: 15 of 38 patients (39.5%) had benign PVT and 23 patients (60.5%) had malignant PVT. Results of CEUS examination were conclusive in 37/38 (97.2%) of the examinations for PVT, allowing the differentiation between benign and malignant thrombosis. When the result was inconclusive, another imaging method was performed (MRI). Conclusion: CEUS is a very good method for the evaluation of benign or malignant nature of portal vein thrombosis.
ACCESSION #
77415597

 

Related Articles

  • Multimodality imaging of primary extrahepatic portal vein obstruction (EHPVO): what every radiologist should know. ARORA, A.; SARIN, S. K. // British Journal of Radiology;Aug2015, Vol. 88 Issue 1052, p1 

    Portal vein thrombosis (PVT) is a frequent complication of liver cirrhosis, but it can also occur as a primary vascular disorder amid absent liver disease. Extrahepatic portal vein obstruction (EHPVO) refers to the obstruction of the extrahepatic portal vein with or without involvement of the...

  • ECOGRAFIA CU SUBSTANÅ¢E DE CONTRAST ÃŽN CARACTERIZAREA FORMAÅ¢IUNILOR CIRCUMSCRISE HEPATICE. Timofte, Oana; Gologan, Elena; Manea, Simona; Bălan, G. // Jurnalul de Chirurgie;2012, Vol. 8 Issue 4, p339 

    Contrast-enhanced ultrasonography (CEUS) became widely used as a method in characterizing focal liver lesions. The extensive use of imaging techniques in differential diagnosis of liver lesions and screening of hepatocellular carcinoma in patients with chronic hepatic diseases, has led to an...

  • Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound. Xu, H.-X.; Lu, M.-D.; Liu, L.-N.; Zhang, Y.-F.; Guo, L.-H.; Xu, J.-M.; Liu, C. // British Journal of Radiology;Oct2012, Vol. 85 Issue 1018, p1376 

    Objectives To assess the value of contrast-enhanced ultrasound (CEUS) in differentiating hepatocellular carcinoma (HCC) from non-neoplastic lesion in cirrhotic liver in comparison with baseline ultrasound. Methods A total of 147 nodules (diameter =5.0 cm) in 133 cirrhotic patients (mean...

  • Surgical technique: new advancements for expanding indications and safety. Torzilli, Guido // Journal of Hepato -- Biliary -- Pancreatic Sciences;Jul2010, Vol. 17 Issue 4, p394 

    The technical issues discussed herein represent part of the panorama of innovative approaches proposed for the surgical treatment of hepatocellular carcinoma (HCC); in particular, the attention is focused on the recent advances in the field of planning the surgical strategy and performing liver...

  • Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma. Martie, Alina; Sporea, Ioan; Popescu, Alina; Şirli, Roxana; Dănilă, Mirela; Şerban, Corina; Ardelean, Melania; Bota, Simona; Şendroiu, Mădălina; Chisevescu, Dorina; Sirli, Roxana; Dănilă, Mirela; Serban, Corina; Sendroiu, Mădălina // Medical Ultrasonography;Jun2011, Vol. 13 Issue 2, p108 

    Aim: Contrast-Enhanced Ultrasound (CEUS) is an imaging method that can discriminate between hepatocellular carcinoma (HCC) and other liver lesions. The purpose of this study is to present our experience concerning the use of CEUS in the characterization of HCCs. Material and...

  • Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature. Qi, Xingshun; Dai, Junna; Yang, Man; Ren, Weirong; Jia, Jia; Guo, Xiaozhong // Gastroenterology Research & Practice;2/24/2015, Vol. 2015, p1 

    A systematic review of the literature was performed to analyze the association between portal vein thrombosis (PVT) and survival in non-liver-transplant patients with liver cirrhosis. PubMed, EMBASE, and Cochrane Library databases were searched for all relevant papers which evaluated the...

  • Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Rossi, Sandro; Ghittoni, Giorgia; Ravetta, Valentina; Torello Viera, Francesca; Rosa, Laura; Serassi, Martina; Scabini, Mara; Vercelli, Alessandro; Tinelli, Carmine; Dal Bello, Barbara; Burns, Peter N.; Calliada, Fabrizio // European Radiology;Aug2008, Vol. 18 Issue 8, p1749 

    The aim was to compare the performances of contrast-enhanced (CE) ultrasonography (US) and spiral computed tomography (CT) in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma (HCC). We studied 50 patients with HCC who had biopsy-proven portal...

  • Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis. Soung Won Jeong; Jae Young Jang; Kwang Yeun Shim; Sae Hwan Lee; Sang Gyune Kim; Sang-Woo Cha; Young Seok Kim; Young Deok Cho; Hong Soo Kim; Boo Sung Kim; Kyoung Ha Kim; Jung Hoon Kim // Gut & Liver;Nov2013, Vol. 7 Issue 6, p696 

    Background/Aims: We investigated the effects of sorafenib monotherapy on advanced hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT) in a clinical setting. Methods: In total, 143 consecutive patients with unresectable HCC were treated with sorafenib. Among these patients, 30...

  • Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Kim, Tae; Lee, Kyoung; Khalili, Korosh; Jang, Hyun-Jung; Kim, Tae Kyoung; Lee, Kyoung Ho // Abdominal Imaging;May2011, Vol. 36 Issue 3, p244 

    Contrast-enhanced ultrasound (CEUS) using microbubble contrast agents has expanded the role of US in the diagnosis of liver nodules in high risk patients for hepatocellular carcinoma (HCC). HCC is typically characterized by arterial hypervascularity and later washout (negative enhancement)....

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics